Multicancer early detection tests hold great promise for finding cancer early enough to save lives, but there are caveats ...

Later this week, the UK National Screening Committee (UKNSC), which advises the Government, publishes its final guidance on screening.

Several experimental prostate cancer drugs have produced striking results in early-stage clinical trials, with at least one ...

Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026 ...

Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding unnecessary harms, says new research.

First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to ...

AMPLIFY: A phase 3 study of 64Cu-SAR-bisPSMA positron emission tomography in participants with biochemical recurrence of prostate cancer. SOLACE: A phase 1 pharmacokinetic, dosimetry, safety, and dose ...

A Super Bowl ad used NFL tight ends to promote a finger-free prostate cancer screening. The ad, starring players like Rob Gronkowski, played heavily on humor to encourage men to get a PSA blood test.

Former Premier League goalkeeper Shaka Hislop says it is "alarming" that tests for prostate cancer are not "regular and "standardised" in the United Kingdom. The 56-year-old was diagnosed with the ...

Opportunistic prostate cancer screening can lead to overdiagnosis of indolent diseases and invasive procedures. A cohort study suggested that a low baseline PSA level in midlife was associated with a ...

The Hastings brothers, from Lancashire in the north west of England, have now been given the all-clear Becca Longmire is a digital news writer-reporter at PEOPLE. She has been working at PEOPLE since ...

Last year, Novartis debuted its first-ever Super Bowl ad with an aim of starting “a movement” around early breast cancer detection, as Victor Bulto, president of Novartis U.S., told Fierce Pharma ...